{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:31Z","timestamp":1788307771226,"version":"build-2803163510"},"reference-count":5,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.1001\/jamaneurol.2021.3287","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T11:02:28Z","timestamp":1630494148000},"page":"1409","source":"Crossref","is-referenced-by-count":44,"title":["Rate of Recurrent Guillain-Barr\u00e9 Syndrome After mRNA COVID-19 Vaccine BNT162b2"],"prefix":"10.1001","volume":"78","author":[{"given":"Shirley","family":"Shapiro Ben David","sequence":"first","affiliation":[{"name":"Health Division, Maccabi Healthcare Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israel","family":"Potasman","sequence":"additional","affiliation":[{"name":"Internal Medicine and Infectious Diseases, Maccabi Healthcare Services, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniella","family":"Rahamim-Cohen","sequence":"additional","affiliation":[{"name":"Health Division, Maccabi Healthcare Services, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"nld210009r3","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"31","key":"nld210009r4","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1016\/j.vaccine.2015.05.013","article-title":"Guillain-Barr\u00e9 syndrome and influenza vaccines: a meta-analysis.","volume":"33","author":"Mart\u00edn Arias","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"nld210009r5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/brain\/awaa444","article-title":"COVID-19 vaccine and Guillain-Barr\u00e9 syndrome: let\u2019s not leap to associations.","volume":"144","author":"Lunn","year":"2021","journal-title":"Brain"},{"key":"nld210009r1","unstructured":"Israeli Ministry of Health. Coronavirus (COVID-19) vaccines. Accessed April 30, 2021. https:\/\/www.health.gov.il\/UnitsOffice\/HD\/PH\/epidemiology\/td\/docs\/365_Corona.pdff."},{"key":"nld210009r2","unstructured":"Centers for Disease Control and Prevention. COVID-19 vaccines for people with underlying medical conditions. Accessed April 27, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ancov\/vaccines\/recommendations\/underlying-conditions.html."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2783708\/jamaneurology_shapiro_ben_david_2021_ld_210009_1636576276.47005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T11:02:18Z","timestamp":1636628538000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2783708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.3287","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740738250.793588485","asserted-by":"object"}]},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}